Evidence map›Paper›PMID 20051222›Full record

ArticleAnalytical biochemistry2010

A mammalian reporter system for fast and quantitative detection of intracellular A-to-I RNA editing levels.

Willemijn M Gommans, Jill McCane, Gregory S Nacarelli, Stefan Maas

Abstract read
In one paragraph

Article in Analytical biochemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. An RNA editing fingerprint of cancer stem cell reprogramming.Journal of translational medicine · 2015
    Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Willemijn M GommansDepartment of Biological Sciences, 111 Research Drive, Iacocca Hall D226, Bethlehem, PA 18015-4732, USA.
Jill McCane
Gregory S Nacarelli
Stefan Maas
IQE (United States) · US

Funding

Regulatory mechanisms for A-to-I RNA editingR15NS057739 · NINDS · LEHIGH UNIVERSITY · PI MAAS, STEFAN · 2008 to 2008
$232k
NINDS NIH HHS NS057739NINDS NIH HHS R15 NS057739
6 · The paper itself

Abstract

An important molecular mechanism to create protein diversity from a limited set of genes is A-to-I RNA editing. RNA editing converts single adenosines into inosines in pre-mRNA. These single base conversions can have a wide variety of consequences. Editing can lead to codon changes and, consequently, altered protein function. Moreover, editing can alter splice sites and influences miRNA biogenesis and target recognition. The two enzymes responsible for editing in mammals are adenosine deaminase acting on RNA (ADAR) 1 and 2. However, it is currently largely unknown how the activity of these enzymes is regulated in vivo. Editing activity does not always correlate with ADAR expression levels, suggesting posttranscriptional or posttranslational mechanisms for controlling activity. To investigate how editing is regulated in mammalian cells, we have developed a straightforward quantitative reporter system to detect editing levels. By employing luciferase activity as a readout, we could easily detect different levels of editing in a cellular context. In addition, increased levels of ADAR2 correlated with increased levels of luciferase activity. This reporter system therefore sets the stage for the effective screening of cDNA libraries or small molecules for strong modulators of intracellular editing to ultimately elucidate how A-to-I editing is regulated in vivo.

Indexed as

Genes, ReporterRNA EditingAdenosineAdenosine DeaminaseAmino Acid SequenceHeLa CellsHumansInosineLuciferasesMicroRNAsMolecular Sequence DataRNARNA-Binding ProteinsADARB1 protein, humanAdenosineAdenosine DeaminaseInosineLuciferasesMicroRNAsRNARNA-Binding Proteins

Identifiers

PMID20051222
PMCPMC2836118
OpenAlexW2012968327

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.